Molecular Microbiology

The Molecular Microbiology Group is interested in understanding the rise of multidrug resistant pathogens and the threat of genetically engineered bioweapons. Their focus has strong intersections with health and security areas.

The Molecular Microbiology group investigates uncultured bacteria, composition and function of the human and environmental microbiomes, mechanisms underlying mutagenesis, and more. Further strengths include the development of platforms for the discovery of new antimicrobials.

Dr. Lewis, a member of this group, directs the Antimicrobial Discovery Center (ADC) located in the Biology Department. Two biotechnology companies, NovoBiotic Pharmaceuticals and Arietis Corporation are spinoffs from the technologies developed at Northeastern and work in collaboration with the Center.

The group publishes in high-profile journals (Nature, Science, PNAS, PloSBiology, PloSPathogens), is supported by substantial funding including grants from NIH, NSF, the Gates Foundation and the Pfeiffer Foundation, and includes a correspondingly large number of team members and collaborators.

Yunrong Chai
Yunrong Chai

Assistant Professor
Expertise: Microbial genomics and biofilm formation

Slava Epstein
Slava Epstein

College Distinguished Professor
Expertise: Microbial ecology, diversity, and biotechnology

Veronica Godoy-Carter
Veronica Godoy-Carter

Associate Professor
Expertise: Molecular Microbiology, DNA Damage Pathways

Kim Lewis
Kim Lewis

University Distinguished Professor; Director, Antimicrobial Discovery Center
Expertise: Molecular Microbiology

Jacqueline Piret
Jacqueline Piret

Associate Professor and Associate Head Advisor
Expertise: Molecular Microbiology